MetaCap

Evolus Insider Trades

NASDAQ: EOLSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

7.73-0.07 (-0.90%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
7 · $1.84M
Shares bought / sold
0 / 281.41K
Net activity
Net selling $1.8 million

Evolus insider activity

Over the last 12 months, Evolus insiders reported 17 transactions on SEC Form 4: 0 open-market purchases and 7 sales. Insiders bought $0 and sold $1.8 million worth of stock, for net insider selling of $1.8 million. The largest seller was MOATAZEDI DAVID, with $1.7 million in reported sales.

The most recent filing shows MOATAZEDI DAVID (See Remarks) selling 105,108 shares at $9.04 on Sep 2, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put EOLS's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

EOLS insider transactions

Evolus insider transactions
DateInsiderTypeSharesValueFiling
Sep 2, 2026MOATAZEDI DAVIDSee RemarksSale105,108$950.02KForm 4
Mar 20, 2026MOATAZEDI DAVIDSee RemarksSale13,669$64.93KForm 4
Mar 20, 2026Avelar RuiSee RemarksSale3,119$14.82KForm 4
Mar 17, 2026Avelar RuiSee RemarksSale29,996$146.63KForm 4
Mar 17, 2026MOATAZEDI DAVIDSee RemarksSale116,720$570.56KForm 4
Mar 16, 2026Avelar RuiSee RemarksOption exercise8,804—Form 4
Mar 16, 2026MOATAZEDI DAVIDSee RemarksOption exercise67,489—Form 4
Feb 17, 2026GILL DAVID NDirectorAward45,559—Form 4
Feb 17, 2026Avelar RuiSee RemarksAward94,913—Form 4
Feb 17, 2026Malik VikramDirectorAward45,559—Form 4
Feb 17, 2026MOATAZEDI DAVIDSee RemarksAward313,212—Form 4
Feb 17, 2026Stewart BradyDirectorAward45,559—Form 4
Feb 17, 2026White Albert G IIIDirectorAward45,559—Form 4
Feb 17, 2026Mitchell TatjanaChief Financial OfficerAward121,489—Form 4
Feb 17, 2026Parschauer Karah HerdmanDirectorAward45,559—Form 4
Dec 22, 2025Avelar RuiSee RemarksSale2,261$16.17KForm 4
Dec 22, 2025MOATAZEDI DAVIDSee RemarksSale10,539$75.36KForm 4
Sep 8, 2025Mitchell TatjanaChief Financial OfficerAward104,603—Form 4
Aug 22, 2025Yamagishi-Dressler TomokoChief Marketing OfficerSale5,722$42.97KForm 4
Aug 15, 2025Stewart BradyDirectorBuy30,000$204.49KForm 4
Jun 16, 2025MOATAZEDI DAVIDSee RemarksSale16,582$164.05KForm 4
Jun 13, 2025MOATAZEDI DAVIDSee RemarksSale111,323$1.12MForm 4
Jun 9, 2025White Albert G IIIDirectorBuy20,000$189.00KForm 4
May 13, 2025Beaver SandraChief Financial OfficerSale6,494$65.07KForm 4
May 12, 2025Avelar RuiSee RemarksSale3,385$33.40KForm 4
May 12, 2025MOATAZEDI DAVIDSee RemarksSale15,787$155.76KForm 4
Mar 27, 2025MOATAZEDI DAVIDSee RemarksSale6,251$77.51KForm 4
Mar 18, 2025MOATAZEDI DAVIDSee RemarksSale103,376$1.37MForm 4
Mar 18, 2025Yamagishi-Dressler TomokoChief Marketing OfficerSale4,536$60.12KForm 4
Mar 18, 2025Beaver SandraChief Financial OfficerSale8,996$119.24KForm 4
Mar 18, 2025Avelar RuiSee RemarksSale27,904$369.87KForm 4
Mar 12, 2025Parschauer Karah HerdmanDirectorSale12,888$167.47KForm 4
Mar 7, 2025Parschauer Karah HerdmanDirectorAward7,364—Form 4
Mar 7, 2025MOATAZEDI DAVIDSee RemarksAward95,399—Form 4
Mar 7, 2025Avelar RuiSee RemarksAward23,776—Form 4
Mar 7, 2025Malik VikramDirectorAward7,364—Form 4
Mar 7, 2025Beaver SandraChief Financial OfficerAward35,663—Form 4
Mar 7, 2025White Albert G IIIDirectorAward7,364—Form 4
Mar 7, 2025Stewart BradyDirectorAward7,364—Form 4
Mar 7, 2025GILL DAVID NDirectorAward7,364—Form 4
Mar 7, 2025BLANK SIMONEDirectorAward7,364—Form 4
Mar 7, 2025Yamagishi-Dressler TomokoChief Marketing OfficerAward17,832—Form 4
Dec 23, 2024Avelar RuiSee RemarksSale2,252$24.44KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related